By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Small Business Innovation Research (SBIR) 

Regional Area      U.S.A.
Phone: 800-382-4634 Fax: 800-462-4128


Company News
CytoSorbents, Inc. To Advance HemoDefend Towards Commercialization With $1.5 Million Phase II SBIR Contract From NHLBI/NIH 10/27/2015 7:53:58 AM
AxioMx Awarded SBIR Grant For Rapid scFv-to-IgG Conversion Development 10/13/2015 12:06:34 PM
Altor BioScience Corporation Announces National Cancer Institute Phase II SBIR Grant Award And Publication Supporting Ongoing Clinical Trial Of IL-15 Super Agonist ALT-803 In Combination With Anti-CD20 Antibody Therapy For Relapsed / Refractory Non-Hodgkin Lymphoma 10/6/2015 10:58:22 AM
Cellectar Biosciences  (NVLT) Awarded $2.3 Million National Cancer Institute Fast-Track SBIR Grant To Advance Phospholipid Drug Conjugate (PDC) Delivery Platform 10/1/2015 7:29:15 AM
Protagonist Therapeutics Receives SBIR Funding For Oral IL-23 Receptor Antagonists For Treatment Of Inflammatory Bowel Diseases 9/24/2015 11:09:45 AM
CalAsia Pharmaceuticals, Inc. Announces Continuation Of Funding Of NIH SBIR Phase I Grant And Key Appointments To Management And Scientific Advisory Board 9/21/2015 12:36:42 PM
Navidea (NAVB) Awarded $1.8M Fast Track NIH SBIR Grant For Evaluation Of A Manocept Agent In Kaposi’s Sarcoma 9/3/2015 10:46:07 AM
Ocata Therapeutics Receives SBIR Grant From The NIH’s National Eye Institute To Develop Proprietary Photoreceptor Progenitor Cell Therapy For Retinitis Pigmentosa 9/1/2015 11:03:39 AM
AxioMx Receives SBIR Grant For DNA-Protein Complex Antigen Development 8/31/2015 9:36:52 AM
Ocata Therapeutics Receives SBIR Grant From NIH To Develop Proprietary Hemangio-Derived Mesenchymal Cell Therapy For Lupus Nephritis 8/24/2015 7:57:45 AM